Companies prioritize high-margin sales to affluent, well-insured markets, aligning with shareholder interests rather than public health goals
Some need longer depending on side effects and weight loss progress
Short-term antiemetic use is common as the body adapts to treatment, but ongoing nausea should trigger re-evaluation
The GIP component becomes more active at this dose, affecting lipid metabolism
Use of liraglutide injection for this indication is supported by a 26-week placebo-controlled clinical trial and a 26-week open-label extension in 134 pediatric patients 10 to 17 years of age with type 2 diabetes mellitus, a pediatric pharmacokinetic study, and studies in adults with type 2 diabetes mellitus [see Clinical Pharmacology (12.3) and Clinical Studies (14.1,14.2)]
More serious side effects can occur in rare cases